Loading…

HealthEquity IncHQYCompetitor analysis, valuation and peers

United States · USD·Financials›Investment Managers

Administrator of health savings accounts (HSAs) and other consumer-directed healthcare benefit accounts for employers.

Momentum strong 60
Mkt cap
$8.05B
US dollars, full cap
Free float
97%
of shares outstanding
$/day
$88.8M
20-day average traded
Fwd P/E
19.3×
forward earnings
ROIC−WACC
n/a
WACC 6.5%
Hurdle
n/a
no reverse DCF
Official | Implied
BB- / BB-
agencies · bond market
Next earnings
13 days
1 Dec 2026
Close · USD$97.31
1D-4.5%
1W-5.5%
1M+0.7%
3M-6.7%
6M+11.2%
YTD+6.2%
1Y-2.9%
ATR %3.4%
Beta0.48
52w lowhigh11.7% off high

What HealthEquity does

Administrator of health savings accounts (HSAs) and other consumer-directed healthcare benefit accounts for employers.

Earns fees per account from employers and health plans, a share of interest on the cash balances in HSAs that it holds, and interchange (fees charged on card payments) when members spend, so higher account balances and interest rates both lift income. Acquired WageWorks, a large benefits administrator, in 2019.

Products and services

  • Health savings accounts (HSA)
  • Flexible spending/commuter benefits
  • HSA investment options

Customers

  • Employers (benefits sponsors)
  • Health plans/insurers (partnerships)
  • Individual HSA holders

Where it sits in the supply chain

  • Financial services/healthcare benefits
  • Health savings account (HSA)…
  • Benefits technology

What could go right

  • HSA account/asset growth (rising deductible plans)
  • Investment-asset fee growth as balances mature

What could go wrong

  • Interest rate sensitivity of HSA cash balances
  • Competition from large insurers bundling HSAs

Moat: narrow (switching costs, scale, distribution). Once an employer's HSA program is set up with payroll/benefits integration, switching administrators is disruptive.

Headquarters: Draper, Utah, US · Founded: 2002 · Employees: 2,814

Named competitors

HealthEquity at a glance

Size HealthEquity (HQY) is a United States Financials company (Investment Managers) with a market value of $8.05B, the 879th largest of 3,085 United States companies the cockpit tracks. Shares closed at $97.31 on 18 Nov 2026.

Performance Over six months the shares gained 11.2%, against -0.2% for the median peer and -2.2% for the United States market (cap-weighted) — 6th highest of 20 in its peer set.

Growth Revenue grew 7.3% over the last twelve months (peer median +12.4%); the operating margin is 26.1% (peer median 34.2%).

Valuation It trades at 19.3× forward earnings against a peer median of 14.5× (6th most expensive of 19).

Backlog Backlog (remaining performance obligations) was $3.10M at 31 Jul 2026, down 73% on a year earlier — 0.0 years of trailing revenue. Backlog detail →

Credit HealthEquity has 1 bond outstanding ($600M), rated BB- by the agencies and trading like BB- at a weighted spread of 177 bp.

Short interest Short interest is 6.6% of the free float (30 Oct 2026).

Next results Next results expected around 1 Dec 2026 (exchange calendar; dates can move).

Relative performance

10011012021 May 202621 Aug 202618 Nov 2026HQY 113Peer median 100
Six months, rebased to 100: HealthEquity against the median of its 20 peers (local-currency closes).

HealthEquity financials

Reported figures in USD; fiscal year ends 2026-01-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue$1.36B$1.31B$1.20B$1,000M$862M
Revenue growth—+9%+20%+16%—
Gross profit$864M$805M$693M$530M$396M
EBITDA$513M$482M$393M$281M$199M
Net income$236M$215M$96.7M$55.7M-$26.1M
Free cash flow$488M$455M$338M$241M$147M
Capital expenditure$53.5M$48.8M$505M$46.1M$119M
Total debt$971M$1.00B$1.11B$933M$994M

Quarterly statements and history in the cockpit →

HealthEquity competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-20%0%+20%+40%-10%0%+10%VZNVCTRBGNNAM-INDIAICG601377AMGSFEFGNVONN2799HDFCAMC360ONESTEPABDNSEICIVZ601136HQY6-month return →1-month return →
Up and to the right = strong over both horizons. HealthEquity is the large dot.

Fundamentals: revenue growth against valuation

-20%0%+20%+40%+60%20×40×VZNVCTRBGNNAM-INDIAICG601377AMGSFEFGNVONNSBIFUNDS2799HDFCAMC360ONESTEPABDNIVZHQYRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. HealthEquity is the large dot.

HealthEquity competitors and peer comparison

Head to head with its named competitors (HQY vs UNH vs WEX vs WBS)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
HealthEquity HQY$8.05B+11%+7%26%19.3×n/a
UnitedHealth UNH$314B-8%+3%5%15.4×3.1%
WEX WEX$5.96B+26%+10%27%8.0×n/a
Webster Financial WBSn/a+7%n/an/an/an/a

How HealthEquity compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

HealthEquity against its 20 peers (data as of 18 Nov 2026)
MeasureHQYPeer medianRank in peer set
1-month return+0.7%+1.4%8th lowest of 21
6-month return+11.2%-0.2%6th highest of 20
Distance from 52-week high-11.7%-15.7%8th highest of 21
Revenue growth (TTM)+7.3%+12.4%7th lowest of 21
Operating margin26.1%34.2%8th lowest of 21
Forward P/E19.3×14.5×6th most expensive of 19
Bond spread177 bp128 bpwidest of 5

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
HealthEquity HQYUnited States$8.05B+11%+7%26%19.3×n/an/a
VZ Holding AG VZN.SWSwitzerland$8.23B+19%+9%45%25.5×n/an/a
Victory Capital VCTRUnited States$7.39B+43%+35%45%14.0×n/an/a
Banca Generali BGN.MIItaly$7.33B+6%+19%38%14.8×n/an/a
Nippon Life India Asset Management NAM-INDIA.NSIndia$7.21B-3%+23%68%38.6×n/an/a
ICG ICG.LUnited Kingdom$6.84B-4%-12%55%11.3×n/an/a
China Industrial Securities 601377.SSChina$6.83B-10%-11%29%12.6×n/an/a
Affiliated Managers AMGUnited States$9.69B+30%+15%23%9.0×n/an/a
Stifel Financial SFUnited States$10.5B-3%+8%22%10.2×n/an/a
EFG International EFGN.SWSwitzerland$6.14B+2%-1%26%14.7×n/an/a
Vontobel VONN.SWSwitzerland$6.06B+32%+11%25%12.8×n/an/a
ChinaLin Securities 002945.SZChina$5.72B-1%+15%25%n/an/an/a
SBI Funds Management SBIFUNDS.NSIndia$11.3Bn/a+21%89%32.4×n/an/a
China CITIC Financial Asset Management 2799.HKHong Kong$5.68B-15%-18%135%3.0×n/an/a
HDFC Asset Management HDFCAMC.NSIndia$12.2B0%+12%80%35.5×n/an/a
360 One Wam 360ONE.NSIndia$5.30B+10%+25%33%37.2×n/an/a
StepStone STEPUnited States$5.27B-16%+56%-15%15.4×n/an/a
Aberdeen ABDN.LUnited Kingdom$5.25B-9%-1%37%14.3×n/an/a
SEI Investments SEICUnited States$12.5B+16%+13%30%15.3×n/an/a
Invesco IVZUnited States$12.6B+6%+17%24%9.0×n/an/a
Capital Securities 601136.SSChina$5.14B-22%+1%36%n/an/an/a

HealthEquity bonds and credit

HealthEquity has 1 bond outstanding with $600M face value. The agencies rate it BB-; its bonds trade like BB-. Weighted yield 6.39%, a spread of 177 bp over government bonds.

Every bond, yield and spread in the cockpit →

HealthEquity backlog

HealthEquity reported $3.10M of remaining performance obligations at 31 Jul 2026, down 73% from a year earlier and down 38% from the previous quarter. That is 0.0 years of trailing revenue already under contract. Book-to-bill last quarter: 0.99.

Questions

Who are HealthEquity's main competitors?
Named competitors: Fidelity HSA (private or unlisted), Optum Financial (UnitedHealth) (UNH), WEX Inc. (WEX), HSA Bank (Webster Financial) (WBS). The cockpit's measured peer set (industry) also includes VZ Holding AG (VZN.SW), Victory Capital (VCTR), Banca Generali (BGN.MI), Nippon Life India Asset Management (NAM-INDIA.NS), ICG (ICG.L), China Industrial Securities (601377.SS).
Is HealthEquity expensive compared with its peers?
On forward p/e it trades at 19.3× against a peer median of 14.5×, 6th most expensive of 19 in its peer set.
How has HealthEquity stock performed?
Over six months to 18 Nov 2026 the shares returned +11.2% against -0.2% for the median peer; over one year -2.9%.
What is HealthEquity's backlog?
HealthEquity's remaining performance obligations (contracted revenue not yet recognised) were $3.10M at 31 Jul 2026, -73% on a year earlier.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.